Substance

DAPAGLIFLOZIN

Global reference: every product and company linked to this substance.

BMS-512148 · dapagliflozin [INN] · DAPAGLIFLOZIN [USAN] · Dapagliflozin [WHO-DD] · DAPAGLIFLOZIN COMPONENT QTERNMET · LYN-045 · QTERNMET XR COMPONENT DAPAGLIFLOZIN

Revenue by product (0)

No revenue reported for this substance in loaded filings.

A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.

Products containing this substance (6)

  • DAPAGLIFLOZIN · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
  • DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
  • FARXIGA · ASTRAZENECA PLC ORDINARY SHARES
  • QTERN · ASTRAZENECA PLC ORDINARY SHARES
  • QTERNMET XR · ASTRAZENECA PLC ORDINARY SHARES
  • XIGDUO XR · ASTRAZENECA PLC ORDINARY SHARES

Companies holding this asset (2)